ABCL (AbCellera Corp) Short-Term Debt to Capital
The price evolution of AbCellera Biologics (ABCL) demonstrates the impact of intermittent cash inflows from partnerships, where the indicator stands at 0.00. The business relies on an AI platform for antibody discovery, earning the trust of global pharma behemoths. Meanwhile, the brand's environmental profile is limited to basic laboratory energy efficiency and the safe handling of reagents, which is typical for the high-tech drug development sector.
Analytical breakdowns for AbCellera Biologics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital AbCellera Biologics|ABCL - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio AbCellera Bio|ABCL - Aggregate Debt Obligations|Debts to Book Capitalization AbCellera Biologics Inc|ABCL - Long-Term Debt Volume|Company Short-Term Debt AbCellera|Quick Liquidity abcellera.com
- company profitability and valuation multiples indicators:
Fundamental valuation:abcellera.com
For AbCellera Biologics (ABCL), given the prolonged monetization cycle of its biotech platform, maintaining liquidity without excessive debt burden is critical. By analyzing this chart of short-term liabilities as a share of capital, an investor assesses the company's reliance on short-term loans relative to equity, where a stable trend confirms financial stability and the absence of default risks while implementing management's long-term scientific strategy.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|tourmalinebio.com (TRML) - Short-Term Debt to Equity Ratio|Precigen (PGEN) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|Septerna Corp - Short-Term Debt to Capital|PVLA - Short-Term Debt to Capital|SVRA: Short-Term Debt to Capital|RIGL (rigel.com) - Short-Term Debt to Equity|ANAB (AnaptysBio) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Astria Therapeutics Inc (ATXS)|Short-Term Debt to Capital ENGN|RAPT - Current Liabilities to Capital|Short-Term Debt to Equity Aerovate Therapeutics JBIO|aclaristx.com - Short-Term Debt to Equity|KYTX - Short-Term Debt to Equity|TLSA: Short-Term Debt to Equity|CABA: Short-Term Debt to Capital|Current Liabilities to Capital Ventyx Biosciences, Inc (VTYX)|Short-Term Debt to Equity Theratechnologies Inc.|AVTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ELDN|Short-Term Debt to Capital Agenus, Inc. (AGEN)|Climb Bio, Inc. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ZURA|aTyr Pharma, Inc. - Short-Term Debt to Capital|ADAG: Short-Term Debt to Equity|IMA: Short-Term Debt to Capital|STTK - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Equillium Inc|Current Liabilities to Capital Connect Pharma CNTB|Short-Term Debt to Equity Immunic, Inc. (IMUX)|Short-Term Debt to Equity ATRA (atarabio.com)|Short-Term Debt to Equity InflaRx IFRX|X4 Pharmaceuticals Inc. (XFOR) - Current Liabilities to Capital|Adicet - Short-Term Debt to Capital|Short-Term Indebtedness to Equity Celularity Inc. (CELU)|INMB: Short-Term Debt to Capital|BRNS - Short-Term Debt to Capital Coefficient|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio SAB Biotherapeutics Inc. (SABS)|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Capital QTTB (Q32 Bio)|Short-Term Debt to Capital geovax.com GOVX|Edesa Biotech - Short-Term Debt to Capital|IBIO: Short-Term Debt to Equity|CARM: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio XTL Bio|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|Short-Term Debt to Equity HCWB|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|AIM: Current Liabilities to Equity|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Ratio of Short-Term Indebtedness to Capital GRI|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND - Short-Term Debt to Capital|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Scinai|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital allakos.com (ALLK)|HOOKIPA Pharma - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IGMS|iTeos - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ocean Biomedical Corp OCEA|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com